TNYA - Tenaya Therapeutics, Inc.

Across the last three months, Tenaya Therapeutics, Inc.'s insiders have reduced their positions by a net 29,656 shares worth roughly $21K.

TNYA sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Ali Faraz	539.8K	-	-
Other	Tingley Whittemore	263.1K	-	-
VP	Higa Tomohiro	118.3K	$93.8K	-
10%	Column Group III Gp, LP	0	-	-

Buys and sells only

10 filings · page 5

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 16, 2023	Patterson Leone D	Chief Fin. and Bus. Officer	Sell	4,452	$3.81	$16,962.12	-6.5%	-49.7%	-21.9%
Aug 16, 2023	Ali Faraz66	Chief Executive Officer	Sell	5,563	$3.81	$21,195.03	-4.5%	-49.7%	-21.9%
Mar 10, 2023	Column Group III Gp, LP74	10% Owner	Buy	6,779	$2.60	$17,595.57	-	+183.5%	+145.2%
Mar 10, 2023	Goeddel David V71	Director, 10% Owner	Buy	6,779	$2.60	$17,595.57	-	+183.5%	+145.2%
Feb 8, 2023	Goeddel David V71	Director, 10% Owner	Buy	1,500,000	$2.60	$3,900,000.00	+15.2%	+136.6%	+85.9%
Feb 8, 2023	Column Group III Gp, LP74	10% Owner	Buy	1,500,000	$2.60	$3,900,000.00	+15.2%	+136.6%	+85.9%
Jan 19, 2023	Column Group III Gp, LP74	10% Owner	Buy	69,739	$2.50	$174,201.05	+0.7%	+40.6%	+50.2%
Jan 19, 2023	Goeddel David V71	Director, 10% Owner	Buy	69,739	$2.50	$174,201.05	+0.7%	+40.6%	+50.2%
Jan 18, 2023	Column Group III Gp, LP74	10% Owner	Buy	185,151	$2.51	$464,827.06	+1.9%	+21.4%	+26.6%
Jan 18, 2023	Goeddel David V71	Director, 10% Owner	Buy	185,151	$2.51	$464,827.06	+1.9%	+21.4%	+26.6%